In pancreatic cancer, silencing RRM2 inactivates the PI3K/AKT/mTOR pathway, and reciprocal regulation of RRM2 and mTOR occurs in mammalian cells.22 This evidence concerns the gene MTOR and pancreatic neoplasm.